- Plant-derived recombinant human serum albumin as a raw material and excipient is increasingly being valued September 28th, at the Asia Biopharmaceutical Innovation Summit (BIC2021) held in Shanghai, Wuhan Healthgen Biotechnology Corp., was invited as a guest to discuss the plant-derived recombinant human serum albumin independently developed based on the rice endosperm high expression... Posted by Site editor|2021-09-29 LearnMore
- Plant-derived Recombinant Human Serum Albumin Injection (HY1001 project) Clinical Trials Phase II Data Progress Report September 26th, China Health Ecology Organization (CHEO) was grandly held in Bo’ao. At the Pharmaceutical Innovation and Capital Market sub-forum of the China Pharmaceutical Innovation Ecological conference (CPIE), which is the one of the six core summits of CHEO, Professor... Posted by Site editor|2021-09-27 LearnMore
- The Global Premiere of Clinical trial Phase I data of recombinant human lactoferrin and Lysozyme Oral Solution (Project HY1002) September 25, 2021, the 6th “China Biomed Innovation and Investment Conference” was successfully held in Suzhou. As the star session of the conference, the Global Premiere of Clinical Data session attracted much attention from all walks of life. This year, there are n... Posted by Site editor|2021-09-26 LearnMore
- The Starting Ceremony of the Construction of Plant-derived Recombinant Human Serum Albumin of 1 Million Vials Production Line Project February 19th, 2021, the 8th day of the first lunar year, Wuhan Healthgen Biotechnology Corp. (Hereinafter referred to as "Healthgen Biotech") had the starting ceremony of the construction of plant-derived recombinant human serum albumin core technology resear... Posted by Site editor|2021-02-19 LearnMore
- The World Premiere of Clinical trial Phase I data of recombinant human serum albumin independently developed by Healthgen Biotech September 27, 2020, the world’s first plant-derived recombinant human serum albumin (OsrHSA) independently developed by Wuhan Healthgen Biotechnology Corp. (Healthgen Biotech) was presented to the world, publicly released the clinical trial phase I data in humans in the Uni... Posted by Site editor|2020-09-27 LearnMore
Copyright ® Wuhan Healthgen Biotechnology Corp. All rights reserved. Terms and Conditions of Use
鄂ICP备12013293号-3
